Revenue by segment/product/region: Land US
Flow – sum over the period · $M
Q2 2018
777$M
All values (40)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 2025 | 5,692 | derived |
| Q3 2025 | 5,585 | reported |
| Q2 2025 | 5,562 | reported |
| Q1 2025 | 5,348 | reported |
| Q4 2024 | 5,534 | derived |
| Q3 2024 | 5,520 | reported |
| Q2 2024 | 5,732 | reported |
| Q1 2024 | 5,566 | reported |
| Q4 2023 | 5,352 | derived |
| Q3 2023 | 5,228 | reported |
| Q2 2023 | 5,172 | reported |
| Q1 2023 | 4,665 | reported |
| Q4 2022 | 4,307 | derived |
| Q3 2022 | 4,195 | reported |
| Q2 2022 | 4,148 | reported |
| Q1 2022 | 3,722 | reported |
| Q4 2021 | 3,898 | derived |
| Q3 2021 | 3,680 | reported |
| Q2 2021 | 4,537 | reported |
| Q1 2021 | 4,963 | reported |
| Q4 2020 | 3,059 | derived |
| Q3 2020 | 2,947 | reported |
| Q2 2020 | 1,866 | reported |
| Q1 2020 | 1,314 | reported |
| Q4 2019 | 1,239 | derived |
| Q3 2019 | 1,200 | reported |
| Q2 2019 | 1,119 | reported |
| Q1 2019 | 915 | reported |
| Q4 2018 | 883 | derived |
| Q3 2018 | 838 | reported |
| Q2 2018 | 777 | reported |
| Q1 2018 | 640 | reported |
| Q4 2017 | 586 | derived |
| Q3 2017 | 559 | reported |
| Q2 2017 | 530 | reported |
| Q1 2017 | 445 | reported |
| Q4 2016 | 433 | derived |
| Q3 2016 | 421 | reported |
| Q2 2016 | 422 | reported |
| Q1 2016 | 367 | reported |
2 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: seg_revenue / country:US
More metrics for Block
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Gross profit by segment
Sources & calculation
- Value
- $777M
- Period
- Q2 2018, ended Jun 30, 2018 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Aug 1, 2018 · 0001512673-18-000011
- Location
- us-gaap:Revenues [srt:StatementGeographicalAxis=country:US]
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $777M | Aug 1, 2018 | 10-Q 0001512673-18-000011 | reported · confidence 1. · current |